Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.

REalloys utilizes its first-to-market processing and metallization capabilities to secure a sovereign supply of heavy rare earths for U.S. defense agencies on an accelerated timeline. Strategic ...

From broad R&D to validated platforms, HPQ advances fumed silica, battery materials, and hydrogen while realigning capital ...

Dec 3 (Reuters) - Excelsior Sciences said on Wednesday it has raised $95 million to develop technology that uses machines and artificial intelligence to accelerate the development and testing of small ...

New offering provides drug developers with flexible and powerful cell line development options for monoclonal antibodies, multi-specific and complex molecules SEATTLE--(BUSINESS WIRE)-- As drug ...

After recently closing a Bought Deal Offering (including Full Exercise of the Underwriter's Option) and Concurrent Non-Brokered Offering for aggregate gross proceeds of approximately $7,451,000, the ...

As drug developers face increasing pressure to lower prices and accelerate time to market, global biopharmaceutical contract development and manufacturing organization AGC Biologics is expanding its ...